New Fully Automated Preparation of High Apparent Molar Activity (68)Ga-FAPI-46 on a Trasis AiO Platform

A large number of applications for fibroblast activation protein inhibitors (FAPI)-based PET agents have been evaluated in conditions ranging from cancer to non-malignant diseases such as myocardial infarction. In particular, (68)Ga-FAPI-46 was reported to have a high specificity and affinity for FA...

Descripción completa

Detalles Bibliográficos
Autores principales: Da Pieve, Chiara, Costa Braga, Marta, Turton, David R., Valla, Frank A., Cakmak, Pinar, Plate, Karl-Heinz, Kramer-Marek, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840169/
https://www.ncbi.nlm.nih.gov/pubmed/35163938
http://dx.doi.org/10.3390/molecules27030675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840169/
https://www.ncbi.nlm.nih.gov/pubmed/35163938
http://dx.doi.org/10.3390/molecules27030675

Ejemplares similares